ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,368Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 81

$768K Total Retail Price of All Prescriptions

Rank: 22 out of 81

373 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 373 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

10% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,841 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
NAMENDA 385 360 1 11
LEVOTHYROXINE SODIUM 360 300 2 3
SIMVASTATIN 322 271 3 5
DONEPEZIL HCL 317 274 4 8
AMLODIPINE BESYLATE 311 290 5 6
OMEPRAZOLE 302 245 6 4
LISINOPRIL 252 230 7 2
METOPROLOL TARTRATE 237 208 8 7
CITALOPRAM HBR 233 208 9 10
FUROSEMIDE 219 186 10 1
BUMETANIDE 180 158 11 194
METFORMIN HCL 164 135 12 15
EXELON 163 163 13 47
ATORVASTATIN CALCIUM 163 132 13 18
SERTRALINE HCL 159 129 15 19
MIRTAZAPINE 158 158 16 14
POTASSIUM CHLORIDE 156 144 17 16
HYDROCODONE-ACETAMINOPHEN 149 121 S3 18 12
RISPERIDONE 140 137 19 26
WARFARIN SODIUM 134 93 20 9
JANTOVEN 122 119 21 44
HYDRALAZINE HCL 110 102 22 52
QUETIAPINE FUMARATE 103 80 23 31
CLONIDINE HCL 96 93 24 59
DIVALPROEX SODIUM 92 79 25 25
TRAMADOL HCL 90 83 26 17
HYDROCHLOROTHIAZIDE 84 77 27 21
TRIAMTERENE-HCTZ 83 67 28 116
ATENOLOL 80 74 29 28
METOPROLOL SUCCINATE 77 77 30 22
LANTUS 74 63 31 23
LEVETIRACETAM 74 61 31 48
LOSARTAN POTASSIUM 73 69 33 34
ISOSORBIDE MONONITRATE ER 72 72 34 38
ZOLPIDEM TARTRATE 72 58 34 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 70 34 99
CARVEDILOL 71 69 37 27
CLOPIDOGREL 68 65 38 37
ALLOPURINOL 67 59 39 41
ALENDRONATE SODIUM 65 52 40 32
DIOVAN 64 64 41 50
PANTOPRAZOLE SODIUM 62 54 42 72
MELOXICAM 61 51 43 68
FLUTICASONE PROPIONATE 56 50 44 58
OLANZAPINE 54 54 45 55
TAMSULOSIN HCL 52 46 46 29
CIPROFLOXACIN HCL 51 47 47 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.